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A B S T R A C T
Normal aging in humans is associated with progressive decrease in skeletal muscle mass and strength (sarcopenia)
which contributes to frailty and falls. The age associated changes in body composition result from lower levels of ana-
bolic hormones, oxidative damage, neuromuscular alterations and a general decrease in muscle protein turnover. In
this review we discuss the potential mechanisms and physical activity as prevention and treatment of sarcopenia.
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Introduction
Sarcopenia is a term invented by Irwin Rosenberg
1988. The Greek word »sarco« refers to flesh and »penia«
indicates a deficiency. Sarcopenia is a generic term for
the loss of skeletal muscle mass, quality and perfor-
mance associated with normal aging that can lead to
frailty in the elderly. It cannot be considered a disease or
a condition that has a clear diagnostic marker. Namely,
some older individuals have larger muscles and are
stronger than young adults. However, the clearly is a
decline in the average muscle mass1,2 and performan-
ce3,4 associated with senescence. Sarcopenia appears to
begin in the fourth decade of life and accelerates after
the age of approximately 75 years5. Because of the great
increase in the proportion of the population living long
enough that frailty becomes a significant problem, there
is much interest in achieving a better scientific under-
standing of sarcopenia. The hope is that such an under-
standing will lead to better strategies for preventing or
reversing the underlying processes. It occurs in all indi-
viduals to some degree as a consequence of aging, but it
can be accelerated by a variety of factors including
inactivity6, poor nutrition7 and chronic illnes8. Sarcopenia
is harmful as osteoporosis but less well known. The
mechanisms that underline sarcopenia are only beginning
to be elucidated. In this article we will discuss the func-
tional consequences of sarcopenia, potential mechanisms
and possible methods of prevention and treatment.
Muscle Morphology And Aging
Skeletal muscle consists of different fiber types char-
acterized by their specific myosin heavy chain (MHC)
isoforms. In adult human skeletal muscle, using mono-
clonal antibodies specific to MHC isoforms, three major
fiber types can be distinguished: type I, type IIA, and
type IIX fibers with predominance of myosin heavy
chain 1 (MHC 1), 2a (MHC 2a) and 2x (MHC 2x), respec-
tively. Type I fibers are slow-twitch fatigue resistant fi-
bers with greater oxidative capacity, higher mitochon-
drial content and greater capillary density. In contrast,
the type II fibers are fast-twitch fibers with a high
glycolytic capacity. The type II fibers in adult humans
are further subdivided into type IIA that have interme-
diate oxidative and glycolytic capacity and are more fa-
tigue resistant, and type IIX in which predominates
glycolytic activity9. In a comprehensive study of the en-
tire vastus lateralis muscle in 43 male cadavers aged
15–83, Lexell et al. (1986) showed that there is an
age-related loss in fiber number, and between the ages
of 20 and 80 there is about a 50% reduction in the total
fiber number. This loss is more rapid after the age of
sixty. There is a selective loss of fast-twitch type II fibers
as compared to slow-twitch type I muscle fibers10. Some
results indicate that arm and leg muscles are not af-
fected in the same way. Los of muscle strength in leg
muscles was about 40% compared with 30% in arm
muscles, measured between 30 and 80 years of age11.
Recent studies have demonstrated that the mRNA lev-
els of MHC 2a and 2x decrease with age12.
Loss of Motor Neurons / Motor Unit
Remodeling
Age related changes in the neuromuscular system
might play a role in the onset of sarcopenia. The number
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of spinal cord motor neurons and functioning motor
units decline with age13,14. This is a continuous process
throughout life and is considered irreversible14. Human
nerve cells have a predetermined life span and the de-
cline in these cells is dependent on the location in the
body, age and presence of disease15. The motor neurons
are responsible for sending signals from the brain to the
muscles to initiate movement. A motor unit consists of
the motor neuron and all of the muscle fibers innervated
by that neuron. The number of fibers that a motor neu-
ron innervates depends on the function of that certain
muscle. For example, a muscle that requires precise
movements, such as muscles of eye, will have motor
units with a motor neuron innervating a few muscle fi-
bers. Muscles that require less precise movements and
large strength, such as the quadriceps muscle, will have
motor units with motor neuron innervating hundreds
and possibly over a thousand muscle fibers. The loss of
muscle fibers begins with the loss of motor neurons.
Morphological changes in the anterior horn of the spinal
cord, as well as those in the peripheral axon in older hu-
mans and animals, can be accountable for the old-age
muscle atrophy. Motor neurons will die with age result-
ing in a denervation of the muscle fibers within the mo-
tor unit. This denervation causes the muscle fibers to at-
rophy and eventually die, leading to decrease in muscle
mass13. When a motor neuron dies, an adjacent motor
neuron, usually a slow twitch motor neuron may rein-
nervate the muscle fibers, preventing atrophy. Aging
seems to induce »type grouping«, i.e., in young and mid-
dle-aged skeletal muscle the fast and slow fibers are dis-
tributed in a chessboard fashion, whereas in aged mus-
cle the fibers cluster in groups of either slow or fast cells.
This process is called motor unit remodeling. When com-
pared to fast twitch motor units, slow twitch motor
units are slower to contract, produce less muscle force.
Motor unit remodeling by slow twitch motor neurons
leads to less efficient motor units. The remodeled slow
twitch motor unit will have less precise control of move-
ments, less force production and slowing of muscle me-
chanics5,13,14. This may help explain the loss of balance
and speed of movement with age. In addition, dener-
vation rates of fast twitch muscle fibers may exceed
reinnervation rates by slow twitch motor neurons, fur-
ther explaining atrophy of fast twitch muscle fibers in
elderly13.
Satellite Cells and Aging
The ability of skeletal muscle to grow or become re-
paired upon injury is principally dependent on a popula-
tion of progenitor cells called satellite cells. These cells
are present between the sarcolema of the mature fiber
and its basal lamina16. Skeletal muscle regenerative ca-
pacity has been shown to decline with age17,18, and
Carlson (1995) has suggested that a decrease in regen-
eration potential could contribute to a reduction in mus-
cle mass in older individuals19. Satellite cells are quies-
cent in normal adult muscle, although they can be
induced to proliferate under certain conditions to add
myonuclei to existing fibers or to form new muscle fi-
bers. Research in animals has indicated that the num-
ber or percentage of satellite cells is significantly dimin-
ished in older skeletal muscle, thus providing a poten-
tional basis for the decline in muscle regeneration and
adaptation potential in older animals20–23. Snow (1977)
reported a 50% decrease in satellite cell number be-
tween the ages of 8 and 30 months in the soleus muscle
of mice and rats, and also suggested that the satellite
cells in older muscles were less metabolically active
than those of young animals, based on morphological
criteria23. Gibson and Schultz (1983) reported similar
differences in satellite cell proportions in the extensor
digitorum longus muscle between young and old rats
but not between adult and old ones21. In addition, sev-
eral morphological changes have been noted in satellite
cells in adult compared to young animals, including de-
creased quantities of endoplasmatic reticulum, golgi
and ribosomes22. Possible changes in satellite cell char-
acteristics in older human skeletal muscle are unclear
and the studies that have been completed are associated
with limitations in scope and methodology24,25. Schmal-
bruch and Hellhammer (1976) reported a lover satellite
cell proportion (0,6%) in a 73-year-old male compared to
a satellite cell proportions (4%) in eight adults between
20 and 34 years of age26. However, no other older sub-
jects were assessed in that investigation. Hikida et al
(1998) reported similar proportions of satellite cells (2%)
in young and older men27. Perhaps a more important is-
sue than the number of satellite cells is the environment
that regulates the activation, proliferation and terminal
differentiation of satellite cells28–30.
Protein Synthesis and Aging
Another factor affecting sarcopenia is the rate of
muscle protein synthesis. The quality and quantity of
protein in the body is maintained by a continuous repair
process, which involves both, protein breakdown and
synthesis, whose balance determines the protein con-
tent in the body31. With age, the changes in whole body
protein turnover reflect a decreased synthesis rate ra-
ther than an increased catabolic rate15. Additionally, re-
search has consistently reported that muscle protein
synthesis rates are lower in older adults when compared
to young adults13,31–33. Thus a decrease in muscle pro-
tein synthesis will result in the loss of muscle mass.
Hormones, Growth Factors and Cytokines
The underlying biological mechanisms that account
for the development of age related sarcopenia are proba-
bly complex and not yet sufficiently identified. To some
extent, even masters athletes develop sarcopenia and,
therefore, biological mechanisms, which are intrinsic to
aging and independent of behavior and environment,
should be hypothesized.
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Aging is associated with several changes in hor-
monal levels including decrease in the concentrations of
growth hormone (GH), testosterone (T), and insulin-like
growth factor-I (IGF-I). A decrease in concentrations of
these hormones and growth factors may be one of the
causes to the development of sarcopenia. GH and IGF-I
play a dominant role in the regulation of protein metab-
olism; GH and T are required for protein maintenance;
and IGF-I levels are positively correlated with the mus-
cle protein synthesis rates, specifically myofibrillar pro-
tein (actin and myosin filaments)5. A sustained decrease
in these hormones and growth factor is linked to a de-
crease in muscle mass and increase in body fat5. Al-
though these hormones are involved in protein metabo-
lism and maintenance, there is conflicting evidence
whether hormone replacement is effective in maintain-
ing or gaining muscle mass14.
As people age, they develop numerous minor ail-
ments (e.g., arthritis, recurrent infections, tumors, pres-
sure ulcers) that result in inflammatory responses. Ele-
vated cytokines, especially interleukin-6 (IL-6), have
been associated with a decline in function and frailty in
older persons34–36. It is unclear whether the increase in
circulating IL-6 levels associated with normal aging is
enough to cause muscle atrophy36,37.
Oxidative Damage
Normal cellular metabolism generates various radi-
cals (»free radicals«) that can react with proteins, DNA
and lipids. These radicals include reactive oxygen and ni-
trogen species and reactive aldehydes. Reactive oxygen
species (ROS) are produced within muscle mitochondria
where large quantities of ATP are created by the electron
transport chain38. All these reactive elements, but espe-
cially the hydroxyl radical, may be harmful producing ox-
idative damage to other molecular components of the cell
including: peroxidation of membrane phospholipids, mo-
dification of nuclear DNA or alteration of proteins caus-
ing enzymatic changes and proteolysis. The challenge
addressed by the ROS to the different cellular compo-
nents is known as »oxidative stress«39–41. Interestingly,
there is no direct evidence that the production of ROS
and the rate of oxidative stress increase with age42. How
crucial oxidative damage is to muscle function in old age
has yet to be investigated.
Lifestyle Factors
Sarcopenia is accelerated with a lack of physical ac-
tivity, especially the lack of overload to the muscle, as in
resistance exercise. The amount of physical activity gen-
erally declines with age. Physically inactive adults un-
dergo a faster and greater loss of muscle mass than
physically active adults. However, sarcopenia is not
completely prevented by exercise, as it is also evident,
but to a lesser degree, in physically active individuals. It
is possible that if the physical activity is not sufficient in
intensity and duration to recruit fast twitch muscle fi-
bers it may lead to fast twitch fiber atrophy and the de-
velopment of sarcopenia14. An additional factor in the
development of sarcopenia may be an inadequate en-
ergy intake. Many older individuals may not be taking
in enough calories and/or protein to sustain their mus-
cle mass43.
Resistance training has been shown to be a powerful
intervention in the prevention and treatment of sar-
copenia13. Resistance training has been reported to posi-
tively influence to the neuromuscular system, hormone
concentrations, and protein synthesis rates. According
to Roubenhoff (2001) and Roth et al. (2000), a properly
designed resistance-training program may increase mo-
tor neuron firing rates, improve muscle fiber recruit-
ment, and create a more efficient motor unit13,14. An in-
creased motor neuron firing rate combined with an
increased recruitment of muscle fibers would lead to
faster muscle contractions and greater force production.
Although protein synthesis rates decrease with age,
it is found that progressive resistant training can in-
crease protein synthesis rates in two weeks. Hasten et
al. (2000) reported that following a two-week supervised
resistance training program muscle protein synthesis
rates increased up to 182% from baseline in seven 78–84
year old persons33. Yarasheski and colleagues (1993)
also found that muscle protein synthesis rates in older
adults (63–66 years old) increased significantly in re-
sponse to two weeks of resistance training44. In addi-
tion, Yarasheski et al (1999) reported that three months
of supervised progressive resistance training increased
the rate of muscle protein synthesis by approximately
50% in seventeen frail 76–92 year old men and wo-
men32. These findings suggest that older men and wo-
men retain the ability to increase the rate of muscle pro-
tein synthesis in response to acute and long-term pro-
gressive resistance training. Furthermore, acute and
long-term resistance training increases the number of
satellite cells in the trained muscle, leading to faster
muscle regeneration13. Exercise, also, may have a di-
rect, positive effect on the inflammatory pathway to
sarcopenia45, but these preliminary data should be con-
firmed in a longitudinal investigation.
Conclusions
The frailty of old age has emerged as an important
public health problem because it impairs mobility and
quality of life, and increases the risk of falls and the uti-
lization of health care resources. Based on alredy known
data, there is good reason to believe that an appropriate
combination of hormones and local growth factors would
be useful, but much needs to be learned about how to de-
liver these agents without inducting adverse effects. In
fact, while our hopes for future treatment and preven-
tion lay on the discovery of new pharmacological inter-
vention, exercise is currently our sole solid resource.
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STARENJE SKELETNIH MI[I]A ^OVJEKA
S A @ E T A K
Starenje je u ljudi povezano sa progresivnim smanjenjemmi{i}ne mase i snage (sarkopenija) {to dovodi do slabosti
i povreda. Tjelesne promjene koje se doga|aju starenjem posljedica su smanjenih razina anaboli~kih hormona, oksi-
dativnog o{te}enja, neuromuskularnih promjena i op}enitog smanjenja metabolizma bjelan~evina u mi{i}u. U ovom
preglednom ~lanku raspravljamo o mogu}immehanizmima sarkopenije i ulozi fizi~ke aktivnosti u njenoj prevenciji.
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